3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
10
Active not recruiting
8
Completed
3
Not yet recruiting
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
41
Breast Neoplasms
31
Neoplasms
28
Neoplasm Metastasis
23
Melanoma
20
Leukemia, Myeloid, Acute
20
Prostatic Neoplasms
19
Colorectal Neoplasms
17
Multiple Myeloma
16
Lung Neoplasms
16
Recurrence
13
Myelodysplastic Syndromes
13
Squamous Cell Carcinoma of Head and Neck
12
Lymphoma, Non-Hodgkin
12
Carcinoma, Renal Cell
12
Ovarian Neoplasms
11
Lymphoma, Large B-Cell, Diffuse
11
Carcinoma, Hepatocellular
11
Urinary Bladder Neoplasms
10
Uterine Cervical Neoplasms
9
Pancreatic Neoplasms
9
Glioblastoma
9
Head and Neck Neoplasms
8
Stomach Neoplasms
7
Rectal Neoplasms
7
Lymphoma, Follicular
7
Glioma
7
Brain Neoplasms
7
Solid Tumor
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Interventions
durvalumab
1
Oxaliplatin
1
Leucovorin
1
Gemcitabine
1
Folfox protocol
1
Fluorouracil
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Gallbladder Neoplasms
×
90 days
×
Clear all
NCT05712356
2026-05-26
BOLSTER
Lisata Therapeutics, Inc.
Phase 2
Terminated
66 enrolled
12 charts